Searched for
MRNA 1273
SII is working on an Omicron-specific vaccine, may launch it by the end of this year: ReportSII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax. Poonawalla further...- Moderna's new booster produces stronger response against OmicronModerna has been studying the so-called bivalent vaccine, which targets both Omicron and the original coronavirus strain to determine if it...
- Moderna COVID-19 shot more likely to cause heart inflammation than Pfizer's, study showsModerna's COVID-19 vaccine is up to four times more likely to cause inflammation of the heart muscle, a very rare side effect, than its riv...
- Vaccine explainer: I am fully vaccinated. When do I need a booster?The worst way to determine when boosters are needed would be to wait for infection rates to rise in vaccinated people. It would be the simp...
- WHO gives Emergency Use Authorisation to Moderna's COVID jabAccording to The Hill, the shot from Moderna joins shots from Pfizer-BioNTech, AstraZeneca-SK Bio, Serum Institute of India and Janssen on ...
- Moderna begins study of COVID-19 vaccine in kidsModerna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less ...
- COVID-19 vaccine: American experts meet ahead of expected approval for Moderna's candidateThe meeting comes after the Pfizer-BioNTech vaccine received an emergency use authorization and the first three million doses were distribu...
- US buys additional 100 million doses of Moderna vaccineThe agreement brings the total number of Moderna doses bought by the US to 200 million, enough to immunize 100 million people with the two-...
- Moderna vaccine confers at least 3 months immunity, shows studyResearchers at the National Institute for Allergies and Infectious Diseases (NIAID), which co-developed the drug, studied the immune respon...
- Moderna to supply up to 125 mn COVID-19 vaccine doses globally in first quarterThe company said 85 million to 100 million of those doses would be available in the United States, with 15 million to 25 million available ...
- COVID-19: Moderna submits vaccine data to obtain emergency use authorisation"Moderna's data for the emergency use authorisation request for mRNA-1273 has been submitted to the US FDA," Moderna tweeted on Monday.
- Moderna's mRNA coronavirus vaccineIt will seek emergency use authorization from the U.S. Food and Drug Administration and conditional approval from the European Union on Mon...
- Moderna vaccine results 'stunningly impressive,' Fauci tells AFP"The idea that we have a 94.5 percent effective vaccine is stunningly impressive. It is really a spectacular result that I don't think anyb...
- Moderna COVID-19 vaccine could be ready for use by end of year, US saysThe trial is the first such late-stage study under the Trump administration's program to speed development of measures against the novel co...
- Chinese COVID-19 vaccine candidate produces immune response in animals: StudyA COVID-19 vaccine candidate currently undergoing early-stage human trials in China can produce a "robust" immune response against the nove...
- Moderna phase 3 Covid-19 vaccine trial could still begin in JulyThe Moderna vaccine candidate is an RNA-based vaccine designed to help the body produce antibodies that protect against Covid-19.
- Wipro founder Azim Premji is an early investor in US firm ModernaWipro founder Azim Premji is an investor in Moderna, the firm that has emerged a frontrunner for Covid vaccine.
- US-based firm leads COVID-19 vaccine race, clinical trials show promising early results: ExpertsCautioning that a vaccine is still months, maybe even a year away, experts said the US-based biotechnology firm's results have propelled it...
- US drugmaker reports promising early results from COVID-19 vaccine testThe Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...
- US begins first human trial of coronavirus vaccine: OfficialsThe vaccine is called mRNA-1273 and was developed by the NIAID scientists and their collaborators at the biotechnology company Moderna, Inc...
Load More
